MedTrace Logo

Development and Evaluation of a Web-based Diet Quality Screener for Vegans (VEGANScreener)

NCT06032234 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 89

Last updated 2024-12-03

No results posted yet for this study

Summary

The primary objective of this study is to assess the construct validity and criterion validity for associations of the VEGANScreener with nutrient intakes from reference methods and associations with biomarkers of dietary intake. The investigators hypothesize that the screener is a valid tool to assess diet quality in the vegan population. The study will assess construct validity by testing whether the measure relates as it should to other measures (e.g., age, gender, education, SES differences).

The investigators will assess concurrent and predictive validity (types of criterion validity) by evaluating associations and agreement between 'gold standards', such as diet records, biomarkers, and multi-metabolite signatures of intake. The investigators will examine associations of vegan diet quality with biomarkers of nutritional status, biomarkers of disease, and anthropometric measures and hypothesize that a higher diet quality in vegans is associated with a more favourable profile among vegans, for example, a lower blood pressure. This study is part of the European VEGANScreener Consortium.

Conditions

  • Healthy

Interventions

OTHER

This is an observational study

This is an observational study

Sponsors & Collaborators

  • Berner Fachhochschule

    collaborator UNKNOWN

  • Isabelle Herter-Aeberli

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-12
Primary Completion
2024-03-30
Completion
2024-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06032234 on ClinicalTrials.gov